EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?

Florian Rieder, Dominik Bettenworth, Jin Imai, Yutaka Inagaki

Inflammatory Intestinal Diseases · 2016 · 1 (1) · 41-49

DOI: 10.1159/000445135 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammatory Intestinal Diseases, online erschienen am 19.03.2016. Verfasst von Florian Rieder und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, Ohio, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Intestinal fibrosis and liver fibrosis represent a significant burden for our patients and health-care systems. Despite the severe clinical problem and the observation that fibrosis is reversible, no specific antifibrotic therapies exist. Summary: In this review, using an ‘East-West' scientific collaboration, we summarize the current knowledge on principal mechanisms shared by intestinal fibrosis and liver fibrosis. We furthermore discuss inflammation as the cause of fibrogenesis in both entities, depict unique features of intestinal and hepatic fibrosis, and provide a future outlook on the development of antifibrotic therapies. Key Messages: A collaborative effort in the field of fibrosis, covering multiple organ systems, will have the highest chance of leading to the development of a successful antifibrotic intervention.

Schlagwörter

Stichwörter der Autor:innen

Extracellular matrixInflammatory bowel diseaseLiver cirrhosisOrgan fibrosis

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland, Ohio, USA.
  • Department of Pathobiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Department of Medicine B, University Hospital of Münster, Münster, Germany.
  • Center for Matrix Biology and Medicine, Graduate School of Medicine, Tokai University, Isehara, Japan.
  • Department of Gastroenterology, Tokai University School of Medicine, Isehara, Japan.
  • Department of Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Rieder, F., Bettenworth, D., Imai, J., & Inagaki, Y. (2016). Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?. Inflammatory Intestinal Diseases, 1(1), 41-49. https://doi.org/10.1159/000445135

Vancouver

Rieder F, Bettenworth D, Imai J, Inagaki Y. Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?. Inflammatory Intestinal Diseases. 2016;1(1):41-49. doi:10.1159/000445135

BibTeX
@article{Rieder2016,
  author = {Rieder, Florian and Bettenworth, Dominik and Imai, Jin and Inagaki, Yutaka},
  title = {Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?},
  journal = {Inflammatory Intestinal Diseases},
  year = {2016},
  volume = {1},
  number = {1},
  pages = {41--49},
  doi = {10.1159/000445135}
}
Kostenlos starten →